Department of Medicine

New treatment option for metastatic colorectal cancer prolongs survival

Research conducted at Vanderbilt points to a new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options.

Kate Whitley is participating in a free virtual support group at VUMC for those with Long COVID.

Virtual support group helps people with Long COVID

In addition to receiving her medical care at Vanderbilt University Medical Center, Kate Whitley is one of about 100 patients participating in a free virtual support group program for those with Long COVID at VUMC.

NIH grant boosts international TB research consortium

A new grant will help support Vanderbilt’s RePORT Brazil, one of an international consortium’s six regional tuberculosis research programs.

A Vanderbilt study shows that reducing consumption of simple sugars helped improve gastroesophageal reflux disease.

Maternal diet influences postnatal diabetes risk

Studies in a primate animal model suggest that islet hyperfunction — which in humans is associated with increased fat mass and Type 2 diabetes — is programmed in offspring by a maternal Western-style diet during pregnancy.

Targeting calcium handling in A-fib

The drug ent-verticilide reduced A-fib incidence and duration in an animal model, suggesting it may be a viable therapeutic option.

photo of William Dupont

Study discovers that tumor mutation burden predicts survival outcome

The expected course of a patient’s cancer prognosis has traditionally been judged by its type, stage and microscopic aggressiveness, but patients with the same presentation can still have widely divergent outcomes. Researchers from Vanderbilt-Ingram Cancer Center have discovered that differences in tumor mutation burden are a major reason for this divergence.

1 28 29 30 31 32 123